Skip to content

Discontinued — last reported Q4 '23

Gross Profit at other companies

Scilex Holding Company logo
Scilex Holding CompanySCLX
$4.17M+15.1%
TEC
Bio-TechneTECH
$208.29M-2.9%
Boston Scientific logo
Boston ScientificBSX
$3.61B+12.6%
Medtronic logo
MedtronicMDT
$6.41B+10.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$15.96B+9.8%

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: BioSig Technologies, Inc.’s 10-K, filed April 16, 2024, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s gross profit?
BioSig Technologies, Inc. (STEX) reported gross profit of $12K in Q4 2023.
How has BioSig Technologies, Inc.'s gross profit changed year-over-year?
BioSig Technologies, Inc.'s gross profit decreased by 88.9% year-over-year, from $108K to $12K.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.